BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Baxter
Fuji
Johnson and Johnson
Healthtrust
Fish and Richardson
Colorcon
Queensland Health
Citi
McKesson

Generated: January 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 078084

« Back to Dashboard

NDA 078084 describes METRONIDAZOLE IN PLASTIC CONTAINER, which is a drug marketed by Baxter Hlthcare Corp, Hospira, and Mylan Labs Ltd, and is included in three NDAs. It is available from four suppliers. Additional details are available on the METRONIDAZOLE IN PLASTIC CONTAINER profile page.

The generic ingredient in METRONIDAZOLE IN PLASTIC CONTAINER is metronidazole. There are eighteen drug master file entries for this compound. Eighty-five suppliers are listed for this compound. Additional details are available on the metronidazole profile page.
Summary for 078084
Tradename:METRONIDAZOLE IN PLASTIC CONTAINER
Applicant:Baxter Hlthcare Corp
Ingredient:metronidazole
Patents:0
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details
Pharmacology for NDA: 078084
Ingredient-typeNitroimidazoles
Medical Subject Heading (MeSH) Categories for 078084
Suppliers and Packaging for NDA: 078084
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
METRONIDAZOLE IN PLASTIC CONTAINER metronidazole INJECTABLE;INJECTION 078084 ANDA Pfizer Labs, Division of Pfizer Inc 0069-2390 0069-2390-01 24 BAG in 1 CARTON (0069-2390-01) > 100 mL in 1 BAG
METRONIDAZOLE IN PLASTIC CONTAINER metronidazole INJECTABLE;INJECTION 078084 ANDA West-ward Pharmaceutical Corp 0143-9772 0143-9772-26 100 mL in 1 BAG (0143-9772-26)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength500MG/100ML
Approval Date:Mar 31, 2008TE:APRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
Deloitte
Chubb
Chinese Patent Office
McKinsey
Boehringer Ingelheim
Merck
Fish and Richardson
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot